Media availability: The role of biomedical research in malaria eradicationNovember 02, 2009WHAT: Although malaria has been controlled in many local and regional populations, the permanent elimination of malaria parasites throughout the world remains an elusive goal, and the disease continues to claim nearly one million lives each year. In 2007, Bill and Melinda Gates called for a renewed effort to eradicate malaria worldwide. Some skeptics have questioned the feasibility of doing so because of failed attempts to eradicate malaria in the 20th century. In a new commentary, National Institutes of Health scientists B. Fenton Hall, M.D., Ph.D., and Anthony S. Fauci, M.D., director of the NIH National Institute of Allergy and Infectious Diseases (NIAID), discuss the lessons learned from past attempts to eradicate malaria and identify key challenges to achieving success today. The renewed effort to eradicate malaria will require a long-term commitment that incorporates multiple activities, interventions and approaches, they assert. As success in controlling malaria is achieved, the behavior and distribution of malaria parasites and the mosquitoes that spread them are likely to change. Scientists must be prepared to anticipate these changes and alter their strategies to keep ahead of them by developing a robust pipeline of new tools and interventions. The authors note that such a pipeline will require a sustained research effort, as NIAID recently outlined in the Strategic Plan for Malaria Research and the NIAID Malaria Research Agenda. NIAID is the lead U.S. government agency that supports basic biomedical and clinical research in malaria. To reach the goal of malaria eradication, the authors write that several research challenges must be addressed and overcome. These include * Translating basic research advances into usable malaria interventions * Developing a rapid point-of-care diagnostic test that can be used to detect infection in people without symptoms of malaria, which will become even more important to the eradication effort as malaria becomes less prevalent * Finding vaccines and other interventions that block the malaria parasite at different stages of its life cycle * Understanding in more detail not only the most deadly malaria parasite, Plasmodium falciparum, but also non-falciparum parasite species * Maintaining a vigorous, long-term research effort as scientists and public health personnel work to eliminate and eradicate malaria from every part of the globe Although these challenges are formidable, the authors conclude that with long-term commitment and sustained effort, malaria eradication can be achieved. In a second commentary, NIAID malaria experts Louis H. Miller, M.D., and Susan K. Pierce, Ph.D., argue that malaria eradication will not be possible with existing tools. What is needed, the authors contend, is a modern-day "Manhattan Project" aimed at developing methods to modify mosquitoes so that they are unable to act as vectors of malaria and to introduce such modifications into multiple mosquito populations in a way that the modification can be spread and sustained within the population. Such an approach will require the recruitment of bright young minds into the field of insect biology and unwavering support of research into malaria vector biology. NIH/National Institute of Allergy and Infectious Diseases |
|||||||||||||||||||||
| Related Malaria Current Events and Malaria News Articles On the Trail of a Vaccine for Lyme Disease: Yale Researchers Target Tick Saliva A protein found in the saliva of ticks helps protect mice from developing Lyme disease, Yale researchers have discovered. The findings, published in the November 19 issue of Cell Host & Microbe, may spur development of a new vaccine against infection from Lyme disease, which is spread through tick bites. Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease. Small nanoparticles bring big improvement to medical imaging If you're watching the complex processes in a living cell, it is easy to miss something important-especially if you are watching changes that take a long time to unfold and require high-spatial-resolution imaging. Prioritizing low-cost, simple health measures would save 2.5 million child lives a year Almost a third of the children under age five who die each year could be saved if governments rebalance health spending to ensure low-cost, simple interventions such as safe water and hygiene, bed nets and basic maternal and newborn care, leading aid agency World Vision said today. Currently, 8.8 million children a year die before age five, most of preventable causes. Drug industry, nonprofits join forces to fight world's neglected diseases Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called "neglected" diseases that claim millions of lives in the developing world each year. U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide. 1930s drug slows tumor growth Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. DNA barcodes: Creative new uses span health, fraud, smuggling, history, more The scientific ability to quickly and accurately identify species through DNA "barcoding" is being embraced and applied by a growing legion of global authorities - from medical and agricultural researchers to police and customs authorities to palaeontologists and others. PATH Malaria Vaccine Initiative shares strategy for developing 'next-generation' malaria vaccines Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria. Malaria is one of the world's deadliest infectious diseases, killing nearly 900,000 people a year, most of them children in sub-Saharan Africa. Global challenges and opportunities in fighting HIV/AIDS and neglected diseases Responding to the HIV/AIDS pandemic and tackling so-called neglected tropical diseases are the focus of the November/December 2009 edition of Health Affairs. More Malaria Current Events and Malaria News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||